MIR4509-2: A Drug Target / Disease Biomarker (G100616228)
MIR4509-2: A Drug Target / Disease Biomarker
MIR4509-2 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the superfamily of evolutionarily conserved transmembrane protein (SMTP) family 2, which includes proteins that play a central role in various cellular processes, including cell signaling, protein transport, and cell-cell adhesion.
One of the most interesting aspects of MIR4509-2 is its potential as a drug target. The MIR4509-2 protein has been shown to interact with several different drug molecules, including small molecules, peptides, and proteins. Additionally, MIR4509-2 has been shown to play a role in the regulation of cellular processes that are often targeted by drugs, such as cell growth, angiogenesis, and inflammation.
Despite its potential as a drug target, MIR4509-2 is not yet a validated drug target. To determine its potential, researchers have used a variety of techniques to study its behavior in a variety of cellular contexts. For example, researchers have used RNA interference to knock down MIR4509-2 expression in cell culture and mouse models, and have found that MIR4509-2 is involved in the regulation of cellular processes, including cell signaling and protein transport.
Another way researchers have studied MIR4509-2 is by using live cell imaging techniques to visualize its localization and interactions with other proteins in the cell. These studies have shown that MIR4509-2 is involved in the regulation of cellular processes that are often targeted by drugs, such as cell growth, angiogenesis, and inflammation.
While MIR4509-2 is an interesting protein, it is not yet clear what its true function is in the cell. However, its potential as a drug target is an exciting area of research, and further studies are needed to determine its true potential.
Protein Name: MicroRNA 4509-2
The "MIR4509-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4509-2 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697
